Data & Statistics
Congenital heart defects (CHDs) are the most common types of birth defects, and babies born with these conditions are living longer and healthier lives. Find more statistics about CHDs below.
Number of U.S. Babies Born with CHDs
- CHDs affect nearly 1% of―or about 40,000―births per year in the United States.1,2
- The prevalence (the number of babies born with heart defect compared to the total number of births) of some CHDs, especially mild types, is increasing, while the prevalence of other types has remained stable. The most common type of heart defect is a ventricular septal defect (VSD).3,4
- About 25% of babies with a CHD have a critical CHD. Infants with critical CHDs generally need surgery or other procedures in their first year of life. [Read summary]
- Prevalence of all types of CHDs, including critical CHDs, varies by state and by type of defect. [Read summary]
Did You Know?
CDC is working on a pilot project with the New York State Department of Health, Emory University in Atlanta, Georgia, and the Massachusetts Department of Public Health to develop tracking of children and adults with CHDs. Understanding health issues and needs across the lifespan is vital to improving the lives of individuals born with these conditions. [Learn More]
Number of U.S. Children and Adults Living with CHDs
- Currently, there are a number of state-based birth defects programs that track CHDs among newborns and young children, but no tracking system exists to look at the growing population of older children and adults with heart defects.
To date, other methods have been used to estimate the total number of children and adults with these defects. For example, one study estimated that, in 2010, about 2 million infants, children, adolescents, and adults were living with CHDs in the United States. Researchers estimated that about 1 million U.S. children and about 1 million U.S. adults were living with CHDs. Overall, there are slightly more adults living with CHDs than children. To obtain this estimate, researchers used data from administrative healthcare databases in Canada to estimate the prevalence of people living with CHDs and applied this to the U.S. Census data from 2010. [Read abstract]
- CHDs are a leading cause of birth defect-associated infant illness and death. [Read article]
- Infant deaths due to CHDs often occur when the baby is less than 28 days old (sometimes called the neonatal period). In a study of neonatal deaths, 4.2% of all neonatal deaths were due to a CHD. [Read article]
- During 1999–2006, there were 41,494 deaths related to CHDs in the United States. This means that CHDs were either the main cause of death or contributed to death in some way. During this time period, CHDs were listed as the main cause of death for 27,960 people. Nearly half (48%) of the deaths due to CHDs occurred during infancy (younger than 1 year of age). [Read article]
- Survival of infants with CHDs depends on how severe the defect is, when it is diagnosed, and how it is treated.
- About 97% of babies born with a non-critical CHD are expected to survive to one year of age. About 95% of babies born with a non-critical CHD are expected to survive to 18 years of age. [Read summary] Thus, the population of people with CHDs is growing.
- About 75% of babies born with a critical CHD are expected to survive to one year of age. About 69% of babies born with critical CHDs are expected to survive to 18 years of age. [Read summary]
- Survival and medical care for babies with critical CHDs are improving. Between 1979 and 1993, about 67% of infants with critical CHDs survived to one year. Between 1994 and 2005, about 83% of infants with critical CHDs survived to one year. [Read summary]
Illness and Disability
- At least 15% of CHDs are associated with genetic conditions.5,6
- About 20% to 30% of people with a CHD have other physical problems or developmental or cognitive disorders.7,8,9
- The occurrence and severity of a developmental disability or delay increases with how complex the heart defect is. For example, more than 80% of individuals with a mild CHD have no developmental disabilities. However, more than half of those with a more critical type of CHD have some form of disability or impairment. Guidelines for screening, diagnosing, and managing developmental disabilities or delay in children with CHDs have recently been developed. [Read summary]
- In the United States, hospital costs for the population of individuals with CHDs in 2004 were about $1.4 billion. Care for individuals with severe CHDs accounted for about $511 million, or about 37%, of the hospital costs associated with CHDs. [Read summary] If we updated these estimates to 2011 dollars, these costs for the population of individuals with CHDs total $1.8 billion.
- In 2005, for a privately insured population in the Unites States, the estimated medical care costs for an average infant with any CHD was about $23,000, and costs were higher for infants with a severe CHD. 10
- In addition to the medical costs of care for CHDs, families of children with CHDs can face other costs, such as lifestyle changes, emotional stress, family uncertainty, and being unable to return to work in order to care for their child. [Read summary]
Key Findings: State actions to adopt newborn screening for critical congenital heart defects
CDC’s Morbidity and Mortality Weekly Report has published a new study looking at state actions to adopt newborn screening for critical congenital heart defects (critical CHDs) using pulse oximetry – a simple, non-invasive way to measure the amount of oxygen in a newborn’s blood.
(Published: June 18, 2015)
Key Findings: Estimated Number of Infants Detected and Missed by Critical Congenital Heart Defect Screening
The journal Pediatrics has published a new study estimating the number of infants with critical congenital heart defects(critical CHDs) potentially detected or missed through universal screening for critical CHDs using pulse oximetry.
(Published: May 11, 2015)
Key Findings: Diabetes before pregnancy and congenital heart defects
In a new CDC study published in the American Journal of Preventive Medicine, researchers found that if women with type 1 or type 2 diabetes had their blood sugar in control before they became pregnant, about 2,670 babies could be born without congenital heart defects (CHDs) each year.
(Published: October 14, 2014)
Key Findings: Estimating the impact of newborn screening for critical congenital heart defects in the United States
In a new study published in JAMA Pediatrics, CDC researchers and partners found about 30% of newborns with a critical congenital heart defect (CCHD) were diagnosed more than three days after birth.
(Published: February 3, 2014)
Key Findings: Costs of Screening for Critical Congenital Heart Defects
Researchers investigated hospitals’ time and cost to screen newborns for critical congenital heart defects.
(Published: January 17, 2014)
Key Findings: Heart Defects
Researchers looked at when women receive their baby's heart defect diagnosis.
(Published: December 17, 2013)
Key Findings: How important is timely detection of Critical Congenital Heart Defects?
CDC researchers found that hospital costs for babies with CCHD may be lower if heart defects are detected before birth hospital discharge
(Published: September 4, 2013)
New Report: A Public Health Science Agenda for Congenital Heart Defects
Report from a Centers for Disease Control and Prevention Expert Meeting
(Published: August 28, 2013)
Heart Defects Care for Life
Specialized care across the lifespan can help children and adults with a CHD live as healthily as possible.
(Published: February 9, 2015)
Heart Defects Study
Heart defects across the lifespan.
(Published: February 10, 2014)
Living with a Heart Defect: One Family's Story
Congenital heart defects affect nearly 1% of infants born in the US. Learn about one family's story.
(Published: February 6, 2012)
Pulse Oximetry Screening for Critical Congenital Heart Defects
What are critical congenital heart defects?
(Published: January 23, 2012)
Five Facts about Congenital Heart Defects
Congenital heart defects are the most common types of birth defects. They affect nearly 40,000 infants born in the US each year.
(Published: January 10, 2012)
- Hoffman JL, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900.
- Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in Atlanta, 1998-2005. J Pediatr. 2008;153:807-13.
- Botto LD, Correa A, Erickson D. Racial and temporal variations in the prevalence of heart defects. Pediatrics. 2001;107(3):e32. [Read summary]
- Bjornard K, Riehle-Colarusso T, Gilboa SM, Correa A. Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005. Birth Defects Res Part A Clin Mol Teratol. 2013;97(2):87-94. [Read summary]
- Oyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PKA, Melbye M. Recurrence of congenital heart defects in families. Circulation. 2009;120;295-301. [Read summary]
- Hartman RJ, Rasmussen SA, Botto LD, Riehle-Colarusso T, Martin CL, Cragan JD, Shin M, Correa A. The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol. 2011;32(8):1147-57. [Read summary]
- Miller A, Riehle-Colarusso T, Alverson CJ, Frias JL, Correa A. Congenital heart defects and major structural noncardiac anomalies, Atlanta, Georgia, 1968-2005. J Pediatr. 2011;159:70-8. [Read summary]
- Limperopoulos C, Majnemer A, Shevell MI, Rosenblatt B, Rohlicek C, Tchervenkov C. Neurodevelopmental status of newborns and infants with congenital heart defects before and after open heart surgery. J Pediatr. 2000;137:638-45. [Read summary]
- Shillingford AJ, Glanzman MM, Ittenbach RF, Clancy RR, Gaynor JW, Wernovsky G. Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics. 2008;121:e759-67. [Read summary]
- Boulet SL, Grosse SD, Riehle-Colarusso T, Correa-Villasenor A. (2010) Health Care Costs of Congenital Heart Defects. In DF Wyszynski, A Correa-Villasenor, & TP Graham (Eds.), Congenital Heart Defects: From Origin to Treatment (p493-501). New York: Oxford University Press, Inc.
- Page last reviewed: July 31, 2015
- Page last updated: July 31, 2015
- Content source: